Literature DB >> 9249766

Lipoprotein(a) induces glomerular superoxide anion production.

S Greiber1, M Kreusel, H Pavenstädt, P Schollmeyer, C Wanner.   

Abstract

BACKGROUND: Lipoprotein(a) (Lp(a)) is considered to accelerate glomerular injury in various forms of renal disease. Several tissue culture studies suggested that biological effects of Lp(a) are inhibitable by oxygen radical scavengers. Since reactive oxygen metabolites (ROM) are important mediators of renal disease, we studied the effects of native and oxidized Lp(a) on generation of the ROM superoxide anion in isolated glomeruli and compared them with the effects of native (nLDL) and oxidized LDL cholesterol (oxLDL).
METHODS: The effect of native and oxidized Lp(a) and LDL on ROM production in isolated rat glomeruli was investigated with a lucigenin chemiluminescence assay.
RESULTS: Native Lp(a) caused a moderate, dose dependent stimulation of glomerular ROM production: Maximum ROM production to 159 +/- 9% of control glomeruli was induced by nLp(a) 20 micrograms/ml. Lp(a)-induced chemiluminescence was completely inhibited by the cell permeable oxygen radical scavenger Tiron (10 Mm). Oxidized Lp(a) (20 micrograms/ml) caused a more pronounced stimulation of ROM production to 204 +/- 12% of control values. Interestingly, only oxLDL, but not nLDL had a significant effect on glomerular ROM production (ox LDL 50 micrograms/ml: 192 +/- 19% of control). Lp(a) stimulated ROM production was completely inhibited by the protein kinase C inhibitor bis- indolyl malemide (BIM): BIM 10(-6) M inhibited 52 +/- 3%, BIM 10(-5) M inhibited 94 +/- 5% of Lp(a)-induced ROM production. ROM production was also inhibited, when intracellular CAMP levels were elevated by forskolin.
CONCLUSION: Lp(a) and oxLp(a) induce the activation of ROM in glomeruli by a pathway that is sensitive to inhibition of protein kinase C and elevation of intracellular CAMP levels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249766     DOI: 10.1093/ndt/12.7.1330

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  4 in total

1.  Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues.

Authors:  Azar Baradaran
Journal:  J Nephropathol       Date:  2012-10-01

2.  Association of Elevated Serum Lipoprotein(a), Inflammation, Oxidative Stress and Chronic Kidney Disease with Hypertension in Non-diabetes Hypertensive Patients.

Authors:  Surapon Tangvarasittichai; Patcharin Pingmuanglaew; Orathai Tangvarasittichai
Journal:  Indian J Clin Biochem       Date:  2016-01-29

3.  Serum lipoprotein (a) associates with a higher risk of reduced renal function: a prospective investigation.

Authors:  Liping Xuan; Tiange Wang; Huajie Dai; Bin Wang; Jiali Xiang; Shuangyuan Wang; Hong Lin; Mian Li; Zhiyun Zhao; Jieli Lu; Yuhong Chen; Yu Xu; Weiqing Wang; Min Xu; Yufang Bi; Guang Ning
Journal:  J Lipid Res       Date:  2020-07-23       Impact factor: 5.922

4.  Preprocedural Lp(a) level and ApoB/ApoA-Ι ratio and the risk for contrast-induced acute kidney injury in patients undergoing emergency PCI.

Authors:  Jun Tao; Wen Dai; Chenglin Ye; Qian Yao; Man Zhou; Yan Li
Journal:  Lipids Health Dis       Date:  2021-10-09       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.